Date: Aug 5, 2024
Category: Health & Technology
In a concerning development, the Australian Therapeutic Goods Administration (TGA) recently announced that intravenous (IV) fluids have been added to the expanding list of medicines in short supply. This shortage is not an isolated incident but part of a larger, global issue affecting healthcare systems worldwide. The primary causes of this deficit include higher-than-expected demand and significant manufacturing challenges. Hospitals are struggling to manage patient care without adequate supplies of these essential fluids, which are critical for a wide range of medical treatments. The shortage underscores the urgent need for coordinated international efforts to address supply chain vulnerabilities and ensure the availability of life-saving medical supplies. Read the source »
Share on:
Researchers have made a groundbreaking discovery, demonstrating how bacteria can trigger itch by stimulating nerve cells in the skin. This revelation holds potential for the development of innovative...
SonoBreasts, the sole clinic in Los Angeles with a SonoCine Automated Whole Breast Ultrasound, is dedicated to making breast health more accessible. Jasmine Khorsandi and SonoBreasts are leveraging...
Recent surveys indicate that consumers are optimistic about AI's potential to revolutionize healthcare, despite some reservations. As AI continues to make headlines, its role in transforming...
A groundbreaking AI model, trained on the life data of over a million individuals, has demonstrated the ability to predict an individual's lifespan with remarkable accuracy. This innovative...
A groundbreaking achievement in medical science, the world's first partial heart transplant has successfully grown valves and arteries after over a year of research. Duke Health's pioneering...
As the one-size-fits-all approach to healthcare evolves, the focus shifts to personalized medicine. This shift promises safer and more effective treatments tailored to individual needs, ultimately...